Market Tracker

01/17 5:19pm ET

Altimmune Inc (NASDAQ:ALT)

1.87
Delayed Data
As of 4:00pm ET
 -0.03 / -1.58%
Today’s Change
1.51
Today|||52-Week Range
14.70
-6.03%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close1.90
Today’s open1.87
Day’s range1.86 - 1.94
Volume124,748
Average volume (3 months)183,023
Market cap$29.7M
Data as of 4:00pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio0.1
Price/Sales40.80
Price/Book0.66

Competitors

 Today’s
change
Today’s
% change
--Molecular Templates ...-0.03-0.24%
NVIVInVivo Therapeutics ...+0.03+4.23%
HSGXHistogenics Corp-0.09-3.35%
AZRXAzurRx BioPharma Inc+0.02+0.57%
Data as of 4:00pm ET, 01/17/2018

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts